SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite
MUMBAI, India, Aug. 5 /PRNewswire/ -- SIRO Clinpharm, a global, full service Contract Research Organization (CRO) founded in India, today announced the successful completion of the implementation phase of the Oracle Life
Science Application Suite (OLSAS) by going live with Oracle S...
Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment
Coiled Patients Compare More Closely to Normal Population Than They Do to Patients Who Previously Underwent Traditional Clipping Surgery
BOCA RATON, Fla., July 28 /PRNewswire-USNewswire/ -- Since the groundbreaking 2002 ISAT International Subarachnoid Aneurysm Trial ...
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
BELLEVILLE, Ontario and CHADDS FORD, Pa., July 10 /PRNewswire-FirstCall/ -- Bioniche Life
Sciences Inc. (TSX: BNC) and Endo Pharmaceuticals (Nasdaq: ENDP ) jointly announced today that Endo has licensed from Bioniche the exclusive rights to develop and market Urocidin(TM) in the U.S. with ...
ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases
BLACK MOUNTAIN, N.C., June 24 /PRNewswire/ -- ALP Life
Sciences, LLC (Company) today announced the Nanoveson(TM) patent has been filed and the Nanoveson(TM) whitepaper is available at www.ALPLifeSciences.com/wp . After completing initial research, the Company is pursuing clinical trials an...
Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
JERUSALEM, June 10 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc.
(OTCBB: ORMP.OB) ( http://www.oramed.com ), a developer of oral delivery
systems, announced that Oramed was chosen to present at the 8th National Life
Science & Technology Week ILSI-BIOMED Conference, Israel 2009. Th...
Advanced Life Sciences Announces Outcome of FDA's Anti-Infective Drugs Advisory Committee Review of Restanza(TM) (cethromycin)
CHICAGO, June 2 /PRNewswire-FirstCall/ -- Advanced Life
Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) announced today that the FDA's Anti-Infective Drugs Advisory Committee voted in the majority that Restanza(TM) (cethromycin) demonstrated safety for the outpatient treatment of adults with m...
Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma
Non-drug Procedure for Asthma Highlighted at ATS 2009
SUNNYVALE, Calif., May 18 /PRNewswire/ -- Results of the Asthma Intervention Research 2 (AIR2) Trial of the Alair(R) Bronchial Thermoplasty System, developed by Asthmatx, Inc., were announced today at ATS 2009, the International Conferenc...
Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples
Data Published in May Issue of Journal of Sexual Medicine
INDIANAPOLIS, May 6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) today announced results from a double-blind, placebo-controlled study which showed that tadalafil 5 mg dose taken once daily was generally well-...
Novel Photoconductive Life Science Research Innovation Enables Rapid, Reproducible, and Non-Invasive Cellular Excitation
From Neurons to Beyond; Advancing the Frontiers of Life
Research Toward Realizing Healthcare Solutions in Areas of Clinical Need
Such as Parkinson's, Alzheimer's, and Autism
BOSTON, Sept. 19 /PRNewswire/ -- Neurosilicon (http://www.neurosilicon.com )
has announced the availability o...
NOVAVAX CEO to Present at 2008 UBS Global Life Sciences Conference
ROCKVILLE, Md., Sept. 19 /PRNewswire-FirstCall/ -- Novavax, Inc.
(Nasdaq: NVAX ) a clinical-stage vaccine company, announced today that Dr.
Rahul Singhvi, President and Chief Executive Officer, will be presenting at
the 2008 UBS Global Life
Sciences Conference in New York, NY. The
Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
PRINCETON, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Pharmasset, Inc.
(Nasdaq: VRUS ) management will present at the UBS Global Life
Conference being held from September 22-25, 2008 at the Grand Hyatt Hotel
in New York City. Schaefer Price, Pharmasset's Chief Executive Officer,
New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition
Early Clinical Results Unveiled at Society of NeuroInterventional Surgery Annual Meeting
LAKE TAHOE, Calif., July 29 /PRNewswire/ -- Early clinical results from
the US and Argentina reveal that a new minimally invasive procedure
successfully eliminates pain and disab...
DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education
EL SEGUNDO, Calif., June 23 /PRNewswire/ -- DaVita Inc., a leading
provider of kidney care services for those diagnosed with chronic kidney
failure and disease (CKD), recently introduced its EMPOWER program, a
series of free community-based workshops that encourage CKD patients to
Caliper Life Sciences' Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
- IVIS Imaging System Provides Real-Time Insight on Viability of Infectious Disease Treatment Options -
HOPKINTON, Mass., April 28 /PRNewswire-FirstCall/ -- Caliper Life
Sciences, Inc. (Nasdaq: CALP ) today announced that the Texas A&M Health
Science Center Research Foundat...
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
NEW YORK, March 26 /PRNewswire/ -- Crystal Research Associates, LLC
announced today that it has issued an Executive Informational Overview(R)
(EIO(R)) on Bioniche Life
Sciences Inc. (TSX: BNC). The full 68-page report
can be found at http://www.crystalra.com .
Bioniche is a Canadian biophar...
Family of Three Americans Become Pain Free and Improve Their Quality of Life With Stem Cell Treatment in Mexico
MONTERREY, Mexico, March 20 /PRNewswire/ -- Optimum Health Regeneration
Center announced the successful treatment of an American family treated for
pain management and impaired mobility. This New Mexico family, ranging in
age from 52 to 78, all recorded significant improvements in reduced pain...
Test for Life Campaign Screens Record Number of DC Residents for HIV/AIDS
More than 275 residents screened for HIV during three testing days in
WASHINGTON, Feb. 28 /PRNewswire-USNewswire/ -- During the month of
February, Test for Life
worked with the Washington Wizards, Congresswoman
Eleanor Holmes Norton (D-DC), Mayor Adrian Fenty and Verizon Washingto...
Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin
-Study Results Show Cethromycin Not Associated with QT Prolongation- -Favorable Cardiac Safety Profile Strengthens NDA-
CHICAGO, Feb. 19 /PRNewswire-FirstCall/ -- Advanced Life
Holdings, Inc. (Nasdaq: ADLS ), today announced positive results from Trial
CL07-001, a thoroug...
GeoVax Labs, Inc. Selected by Georgia Bio as '2008 Deal of the Year' Award Winner in Life Sciences Industry
ATLANTA, Jan. 17 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC
Bulletin Board: GOVX), an Atlanta-based biotechnology company developing
HIV-1/AIDS vaccines, announced it has been named a "2008 Deal of the Year"
award winner by Georgia Bio. Georgia Bio recognized GeoVax for receiving a
The Pittsburgh Life Sciences Greenhouse Relocates Therapeutics Company to Pittsburgh
Cognition Therapeutics, Inc. Begins Operations with a $200,000 Investment from the PLSG
PITTSBURGH, Dec. 4 /PRNewswire/ -- The Pittsburgh Life
Greenhouse (PLSG), the organization providing capital investments and
customized company formation and business gro...
Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
Results of SHEPHERD Phase III Open Label Trial Published in Online Edition of the Journal Blood
CHESHIRE, Conn., Dec. 4 /PRNewswire-FirstCall/ -- Soliris(R)
(eculizumab) therapy reduced hemolysis and improved fatigue, overall
quality of life
and anemia in a diverse popu...
Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
- Screening Determines Efficacy and Safety of Combination Drug Therapies -
HOPKINTON, Mass., Dec. 3 /PRNewswire-FirstCall/ -- Caliper Life
Sciences, Inc. (Nasdaq: CALP ) today launched drug combination services
through Caliper Discovery Alliances & Services (CDAS). These new services
Treating Depression Prolongs Life for Older People with Diabetes
Also This Month: Lessons Learned from the Avandia Controversy
ALEXANDRIA, Va., Nov. 27 /PRNewswire-USNewswire/ -- Depressed, older
adults with diabetes live longer when they are treated for depression,
according to a study in the December issue of Diabetes Care, which
publishes on November...
Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
New rules allow expanded routine screening
WASHINGTON, Nov. 8 /PRNewswire-USNewswire/ -- Today, Test for Life
commended the North Carolina Commission for Public Health and the North
Carolina Rules Review Commission for updating the state laws to include the
Centers for Disease Control and Pr...
Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research
Collaboration with Lentigen Expands Research Applications for RNAi
WALTHAM, Mass., Oct. 22 /PRNewswire-FirstCall/ -- Thermo Fisher
Scientific Inc. (NYSE: TMO ), the world leader in serving science, has
collaborated with Lentigen Corporation to develop a powerful new technology
Alfacell Corporation to Present at UBS Global Life Sciences Conference
SOMERSET, N.J., Sept. 19 /PRNewswire-FirstCall/ -- Alfacell Corporation
(Nasdaq: ACEL ) today announced that Lawrence A. Kenyon, executive vice
president, chief financial officer and corporate secretary, will present an
overview of the company's product development programs at 8:30 a.m. EDT o...
Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
- Company Will Present Seven Posters and sponsor Satellite Symposium at Key Scientific Gathering at McCormick Place in Chicago, September 17 - 20 -
CHICAGO, Sept. 5 /PRNewswire-FirstCall/ -- Advanced Life
Holdings, Inc. (Nasdaq: ADLS ), will present s...
Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
Phase I/II Clinical Studies Set To Begin By Early 2008
WOODRIDGE, Ill., Aug. 28 /PRNewswire-FirstCall/ -- Advanced Life
Sciences Holdings, Inc. (Nasdaq: ADLS ) today announced that the United
States Food and Drug Administration (FDA) has granted Orphan Drug
Designation to its oncolog...
Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
CHICAGO, Aug. 21 /PRNewswire-FirstCall/ -- Advanced Life
Holdings, Inc. (Nasdaq: ADLS ), today announced the commencement of its
collaboration with the National Institute of Allergy and Infectious
Diseases (NIAID), the lead governmental institute supporting biodefense
New International Study Shows Women With Symptomatic Fibroids Delaying Treatment Despite Substantial Burden on Quality of Life
One in five women suffer from fibroid symptoms at least 5 years before
LAS VEGAS, Oct. 29 /PRNewswire/ -- At the annual meeting of the
American Association of Gynecologic Laparoscopists (AAGL), ETHICON Women's
Health & Urology today announced results of a seven-country stu...
Major Discovery Raises Prospect of Better Patient Care By Improving
Platelet Life Span
MELBOURNE, Australia, March 23, 2007 /PRNewswire/ -- Scientists
at WEHI have made a discovery with potentially profound
implications for the care of patients, especially those undergoing
The research team led by Drs Benjamin Kile and David Huang has
discovered that platelet ...
Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase
I/IIa 6-Month Results at 75th Annual Meeting of the American
Association of Neurological Surgeons
Company Announces Extension of Phase I/IIa Trial to 9 mg Dosage
HOPKINTON, Mass., April 16, 2007 /PRNewswire-FirstCall/ --
Sciences announced today that clinical data on its lead
nerve repair therapy, Cethrin(R), were presented in the Neurotrauma
and Critical Care Scientific Sess...
Answerthink and LORENZ Life Sciences Group Announce Strategic
Alliance for the SAP Life Science Industry
MIAMI--(BUSINESS WIRE)--Jun 21, 2007 - Answerthink, Inc. (NASDAQ:
ANSR) announced today that it has formed a strategic alliance with
Sciences Group for the distribution of LORENZ solutions
in North America. Answerthink and LORENZ Life
Sciences Group will
serve midsize companies by integ...
Advanced Life Sciences to Host Conference Call to Discuss Data From
Cethromycin's First of Two Phase 3 Pneumonia Trials
CHICAGO, June 29, 2007 /PRNewswire-FirstCall/ -- Advanced Life
Sciences Holdings, Inc. , today announced that it will host a
conference call and live webcast at 10:00 am (EDT) on Monday, July
2, 2007 to discuss data from Trial CL-06, the first of two pivotal
Phase 3 clinical trials designed to ass...
Advanced Life Sciences Announces Supplemental Efficacy Data from
First Pivotal Phase 3 Pneumonia Clinical Trial
Provides Update to Timeline for Second Pivotal Phase 3 Trial CL-05
CHICAGO, July 02, 2007 /PRNewswire-FirstCall/ -- Advanced Life
Sciences Holdings, Inc. , today announced the confirmation of
supplemental efficacy data from Trial CL-06, the first of two
pivotal Phase 3 clinical trials designed to ...
Suven Life Sciences Presenting Pre-clinical data of their
NCE’s SUVN-502 and SUVN-507at International Brain Research
Organization (IBRO) 2007 World Congress of Neuroscience
HYDERABAD, India, July 5th, 2007 – Several data
presentations from Suven’s portfolio of investigational
neuroscience compounds will be presented at
International Brain Research Organisation (IBRO) 2007 World
Congress of Neuroscience to be held at Melbourne, Australia during
GTC Biotherapeutics to Webcast Corporate Presentation at the C.E.
Unterberg, Towbin Emerging Growth Life Opportunities Conference
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Jul 5, 2007 - GTC
Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced today that
Geoffrey Cox, Ph.D., GTC's Chairman and CEO, is scheduled to
present on Wednesday, July 11, 2007 at 9:00 a.m. during the C.E.
Unterberg, Towbin Emerging Growth Life
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many
Aspects of Daily Life
UC's Overall Psychological Toll Is Greater Than for Asthma,
Rheumatoid Arthritis and Migraines
WAYNE, Pa., May 17, 2007 /PRNewswire/ -- Nearly three out of
four ulcerative colitis (UC) sufferers (73 percent) responding to a
new nationwide survey say not feeling well has become a normal part
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
...out considering the conversion feature. As a result, Isis is recording its convertible debt at a discount, which Isis is amortizing over the expected life
of the debt as additional non-cash interest expense. FSP 14-1 required retrospective application to all periods presented. Accordingly, the amount o...
Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
...mplex biomedical problems in cancer biology, immunology, neuroscience, and metabolic as well as infectious disease. These technologies cut across the life
sciences, and include genomics and proteomics tools, medicinal chemistry, cell-based ultra high throughput screening of genes or compounds, structural...